Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTC Conditioning Regimen for Autologous Stem Cell Transplant in Breast Cancer
NCT00005798Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 1995
- Primary completion
- Aug 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, thiotepa, carboplatin in breast cancer, sponsored by Moffitt Cancer Center. Started Jul 1995; status: completed.
02
Drugs
cyclophosphamidethiotepacarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005798.